NVAX
NOVAVAX INC
NASDAQ · Healthcare · Biotechnology · US
$10.82
−3.91%Leverage
- Debt / equity
- -1.55x
- Net debt / equity
- -0.55x
- Debt / assets
- 0.31x
- Debt / EBITDA
- -1.44x
- Net debt / EBITDA
- -0.51x
Liquidity & coverage
- Current ratio
- 2.33x
- Quick ratio
- 2.30x
- Cash ratio
- 2.18x
- Interest coverage
- -18.80x
- EBITDA / interest
- -17.00x
- Working capital
- $440.5M
Cash & dividend
- FCF / debt
- -0.15x
- Cash flow / debt
- -0.13x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026